Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-1-6
pubmed:abstractText
The dopamine (DA2) receptor agonist 2,10,11-trihydroxy-N-n-propylnoraporphine (TNPA) was tested for effects on 1) intraocular pressure (IOP), 2) aqueous humor flow rate, 3) electrically induced contractions of the cat nictitating membrane, 4) 3H-NE release from isolated rabbit iris-ciliary bodies and 5) cAMP accumulation in the isolated rabbit iris-ciliary body. Unilateral, topical administration of TNPA lowered IOP bilaterally in a dose-related fashion and inhibited the bilateral rise in IOP caused by water gavage. Topical pretreatment with metoclopramide, a DA antagonist, inhibited the ocular hypotensive response to TNPA. Subsequently, TNPA was shown to decrease aqueous humor inflow and IOP in normal rabbit eyes but not in surgically sympathectomized rabbit eyes. TNPA caused dose-dependent suppression of contractions of the cat nictitans, which was inhibited competitively by domperidone, a relatively selective DA2 receptor antagonist. In a test of prejunctional activity, TNPA caused dose-related inhibition of 3H-NE release from isolated, field-stimulated rabbit iris-ciliary bodies, which was inhibited by pretreatment with sulpiride, a relatively selective DA2 receptor antagonist. In a test of postjunctional activity, isoproterenol-stimulated cAMP accumulation in the isolated rabbit ciliary body was not affected by TNPA pretreatment. These results indicate that TNPA's suppressive action on aqueous humor flow rate and IOP is exerted predominantly on prejunctional (DA2) receptors of peripheral sympathetic nerves.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
267
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
822-7
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7902435-Animals, pubmed-meshheading:7902435-Aporphines, pubmed-meshheading:7902435-Aqueous Humor, pubmed-meshheading:7902435-Cats, pubmed-meshheading:7902435-Ciliary Body, pubmed-meshheading:7902435-Cyclic AMP, pubmed-meshheading:7902435-Dopamine Agents, pubmed-meshheading:7902435-Drug Interactions, pubmed-meshheading:7902435-Eye, pubmed-meshheading:7902435-Female, pubmed-meshheading:7902435-Intraocular Pressure, pubmed-meshheading:7902435-Iris, pubmed-meshheading:7902435-Male, pubmed-meshheading:7902435-Metoclopramide, pubmed-meshheading:7902435-Nictitating Membrane, pubmed-meshheading:7902435-Norepinephrine, pubmed-meshheading:7902435-Ocular Hypertension, pubmed-meshheading:7902435-Ocular Hypotension, pubmed-meshheading:7902435-Rabbits, pubmed-meshheading:7902435-Sympathectomy, pubmed-meshheading:7902435-Tritium, pubmed-meshheading:7902435-Water
pubmed:year
1993
pubmed:articleTitle
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
pubmed:affiliation
Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, Georgia.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.